Beyond Air, Inc.

How big is Beyond Air, Inc.?

As of Jun 18, Beyond Air, Inc. has a market capitalization of 24.62 million and reported net sales of 3.02 million with a net profit loss of 54.97 million over the latest four quarters.

As of Jun 18, Beyond Air, Inc. has a market capitalization of 24.62 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the company reported net sales of 3.02 million for the latest four quarters. During the same period, it experienced a net profit loss of 54.97 million.<BR><BR>As of Mar 24, the reporting period for the balance sheet shows shareholder's funds of 25.05 million and total assets amounting to 56.96 million.

What does Beyond Air, Inc. do?

Beyond Air, Inc. is a medical device company developing a nitric oxide generator and delivery system for the Pharmaceuticals & Biotechnology industry. As of December 2024, it reported net sales of $1 million and a net loss of $13 million, with a market cap of $24.62 million.

Overview:<BR>Beyond Air, Inc. is a medical device company focused on developing a nitric oxide generator and delivery system for the Pharmaceuticals & Biotechnology industry.<BR><BR>Financial Snapshot:<BR>- Most recent Net Sales: 1 Million (Quarterly Results - Dec 2024)<BR>- Most recent Net Profit: -13 Million (Quarterly Results - Dec 2024)<BR>- Market cap: USD 24.62 Million (Micro Cap)<BR><BR>Key Metrics:<BR>- P/E: NA (Loss Making)<BR>- Industry P/E: NA<BR>- Dividend Yield: 0.00%<BR>- Debt Equity: 0.22<BR>- Return on Equity: -350.33%<BR>- Price to Book: 1.81<BR><BR>Contact Details:<BR>- Address: 825 E Gate Blvd Ste 320, GARDEN CITY NY: 11530-2135<BR>- Tel: 1 516 6658200<BR>- Website: http://www.ait-pharm.com

Should I buy, sell or hold Beyond Air, Inc.?

Who are in the management team of Beyond Air, Inc.?

As of March 2022, the management team of Beyond Air, Inc. includes Steven Lisi (Chairman and CEO), Amir Avniel (President and COO), and independent directors Ron Bentsur, Robert Carey, William Forbes, Yoori Lee, and Erick Lucera. They are responsible for the company's strategic direction and operations.

As of March 2022, the management team of Beyond Air, Inc. includes the following individuals:<BR><BR>- Mr. Steven Lisi, who serves as the Chairman of the Board and Chief Executive Officer.<BR>- Mr. Amir Avniel, who is the President, Chief Operating Officer, and a Director.<BR>- The Board of Directors also includes independent directors: Mr. Ron Bentsur, Mr. Robert Carey, Dr. William Forbes, Ms. Yoori Lee, and Mr. Erick Lucera. <BR><BR>This team plays a crucial role in guiding the company's strategic direction and operations.

Is Beyond Air, Inc. overvalued or undervalued?

As of June 24, 2024, Beyond Air, Inc. is rated as risky due to overvaluation and significant financial distress, reflected in poor key ratios and a year-to-date stock performance decline of 68.06%, contrasting sharply with the S&P 500's 12.22% gain.

As of 24 June 2024, the valuation grade for Beyond Air, Inc. has moved from does not qualify to risky. The company appears to be overvalued based on its current metrics. Key ratios include a Price to Book Value of 0.93, an EV to EBIT of -0.29, and an EV to EBITDA of -0.31, all indicating significant financial distress and inefficiency.<BR><BR>In comparison to peers, Beyond Air, Inc. has a less favorable EV to EBITDA ratio than Perspective Therapeutics, Inc. at -0.7951 and a stark contrast to Electromed, Inc., which has a fair valuation with an EV to EBITDA of 17.5033. The company's stock has underperformed significantly, with a year-to-date return of -68.06% compared to the S&P 500's gain of 12.22%, highlighting its struggles in the market.

Is Beyond Air, Inc. technically bullish or bearish?

As of September 3, 2025, Beyond Air, Inc. shows a bullish trend despite mixed technical signals and significant underperformance, with year-to-date returns of -68.06% compared to the S&P 500's 12.22%.

As of 3 September 2025, the technical trend for Beyond Air, Inc. has changed from mildly bullish to bullish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD also shows mild bullishness. However, the daily moving averages are bearish, and the weekly KST is bearish, which contrasts with the monthly KST being mildly bullish. The Bollinger Bands and Dow Theory suggest bearish conditions on the weekly and monthly time frames. <BR><BR>Despite the bullish trend change, the stock has significantly underperformed compared to the S&P 500, with year-to-date returns of -68.06% versus the S&P 500's 12.22%. Overall, the current technical stance is bullish but with mixed signals and significant underperformance in the longer term.